Against the Grain with Dr. Chad Edwards | Oklahoma Prolotherapy | Podcast 5 – Part 5

As Seen On...

***This content was written for Revolution Health & Wellness Clinic for marketing purposes only.***

Against the Grain with Dr. Chad Edwards | Oklahoma Prolotherapy | Podcast 5 – Part 5

Brian:  Wow.

Chad:  They completed the studies, and 10 years later hadn’t published it.

Brian: Wow.

Chad: They made their recommendations, or these one to one and a half days faster, based on their incomplete data. Did they just pick the ones that worked and use that? We’ll get into that. In December of 2009, Roche publicly promised independent scientist access to full study reports for selected Tamiflu trials, but to date … And that was as of 2009, the to date part … The company has not made even one full report available. Releasing the trial reports would allow independent academics to answer questions about this globally stockpiled Tamiflu drug, and Roche has been very reluctant.

By October 2013, the Cochran reviewers had received the full clinical study reports for 107 studies from the European Medicines Agency, GlaxoSmithKline, who developed Relenza, and Roche. The Cochran review actually did an update in 2014, and both the Cochran Library and the shortened version as two separate reviews, one per compound, in the British Medical Journal. What did the Cochran review conclude? Well, they said that for adults … They reviewed all the data, and they found that adults actually instead of 1.3 days, they got better 16 hours faster. Sixteen hours.

Brian:  Which seems like an eternity when you have the flu.

Chad:  It can, sure.

Brian: Certainly not an eternity.

Chad: We’re talking about a drug that costs $125 for a five-day pack that has the potential to cause severe psychiatric problems in some patients that gets you better 16 hours faster. Is it worth it? I can’t answer that question, but it raises some serious questions.

Brian: I think there’s a third category there, though, Chad. You’ve articulated it. It’s categorized in a class of drugs that we don’t potentially know all the long-term side effects. Right?

Chad: Oh, without question. Again, released in 1999. We don’t look at long-term stuff. Here’s some other interesting [crosstalk 00:28:38]

Brian: Don’t you just find it interesting, though? Don’t you just find it interesting that the company that makes this is headquartered in Switzerland? You’ve seen it before. There’s these drug companies that emerge overseas in protected areas that really have no incentive to long-term care about the effect of a drug on your body. They have zero incentive.

Chad: Exactly.

Brian:  Why would they make an investment to A) find that out, B) wait for it when there’s billion dollar profits now that are virtually protected from all legislative action? Right?

Chad: Right.

Brian: Which amazes me that the FDA would approve such a vendor on a massive scale based in Switzerland.

Chad:  We’re going to talk more about the flu, the history of flu, flu shot, all that stuff …

Brian: On our next episode.

Chad:  … In our next podcast, but there’s such fear related to flu. My opinion, what I’ve seen … I don’t think the average person fears flu because it will kill them. I think they fear flu because it makes them feel really stinking bad. That’s my opinion. That’s what I’ve experienced. In some cases, it can be life-threatening. It sucks. The flu sucks.

Brian:  I think Tamiflu has done a great job and Marshall is our brilliant single, by the way, the young man that operates the show. Marshall, when you think of Tamiflu, prior to this podcast, I wasn’t thinking … I don’t know about you, but I wasn’t really thinking that it was just a day and a half. For some reason, I was thinking I’ll go get Tamiflu and I’m out with the flu.

Marshall: I thought it treated the symptoms.

Brian: Yeah, like immediately.

Marshall:  Right.

Brian: You’re sick now and in 10 hours, you’re going to be all right.

Marshall: Right. You take it and it immediately starts fixing whatever’s wrong, getting rid of the virus.

Brian: We got that somewhere, right? I mean, based on zero factor … But we got it somewhere.

Marshall: From our friends.

Brian: YouTube, Facebook, something. That’s interesting, Chad. What do you think of that? What do you think of that perception? Is that pretty mainstream when someone comes into your clinic?

Chad:  Oh, I think so. I think that … Yeah, give me that stuff so I feel better.


Chad: You know, you take a decongestant and it works right away. It’s not the case.

Brian: Tamiflu opens up some bigger questions, how people view their own healthcare. I think we live in a fairly face-paced environment. Do you see a lot of people that come into the clinic and they’re just all about immediate fixes? Is that the generation that we live in, that you see?

Chad:Oh, of course. Absolutely. Who doesn’t want to feel better yesterday?

Brian: Generally, what are the ramifications that people don’t generally ask that?

Chad: Correct.

Brian:  Why is that, do you think? What’s your opinion?

Chad: I think it’s a right now society. Older patients, if I’m going to categorize, older patients, 60’s, 70’s, 80’s year old patients, tend to be very compliant. The medicine in their era was very paternalistic, meaning I’m the doctor, here’s your pill. You take this pill. Don’t ask me questions.

Brian:  Process

Chad:They will go home and take their pill, even if that pill makes them every time they stand up, they pass out. They’re not going to question it. Their doctor is going to do it.

Brian: They came from a generation where the idea of a doctor was very respected and trusted.

Chad: Right.

Brian: They did what he said, no matter what, he or she said.

Chad:  Right. What we’ve progressed to today in our younger patients … We’ve had some weather the last couple of days here and roads were crummy yesterday. Older patients will leave a day early …

Brian:  To get to the doctor.

Chad: I’ve seen it. I had patients that would have an 8:00 appointment, and they will leave six hours early to get there. They didn’t want to miss that appointment. You get a 25-year-old, and they’ll be like, “I’m not coming.”